Commitments and Contingencies (Tables)

12 Months Ended

Dec. 31, 2013

Commitments and Contingencies [Abstract]

Current Contractual Obligations

CytRx’s current contractual obligations that will require future cash payments are as follows (in thousands):

	Operating Leases (1)		Employment Agreements (2)		Subtotal		Research and Development (3)		Total
2014	$	337	$	2,575	$	2,912	$	8,490	$	11,402
2015		258		850		1,108		2,106		3,214
2016		228		—		228		943		1,171
2017		255		—		255		681		936
2018		262		—		262		—		262
Thereafter		302		—		302		—		302
Total	$	1,642	$	3,425	$	5,067	$	12,220	$	17,287

____________

(1) Operating leases are primarily facility lease related obligations, as well as equipment lease obligations with third party vendors. The Company recognized lease expenses of $315,134, $324,536 and $321,782 in 2013, 2012 and 2011, respectively.

(2) Employment agreements include management contracts which have been revised from time to time. The employment agreement for the Company’s President and Chief Executive Officer provides for a minimum salary level, which is adjusted annually at the discretion of the Company’s Compensation Committee, as well as for minimum bonuses that are payable. New employment agreements for the Company’s other executive officers are usually entered into annually.

(3) Research and development obligations relate primarily to clinical trials. Most of these purchase obligations are cancelable.